Cover Image

Montelukast deprescribing in outpatient specialty clinics: A single center cross-sectional study

Objective: To identify and evaluate montelukast deprescribing in outpatient specialty clinics. Methods: This was a single-center, retrospective, cross-sectional study conducted at an academic health system in the southern US including 21 specialty clinics. Subjects included adults ≥18 years with an...

Full description

Saved in:

Bibliographic Details
Main Authors:	David C. Foote (Author), Jamie L. Miller (Author), Grant H. Skrepnek (Author), Stephen Neely (Author), Kiya Bennett (Author), Paul M. Boylan (Author)
Format:	Book
Published:	Elsevier, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deprescribing psychotropic drugs in a geriatric psychiatry outpatient clinic
by: Natascha Melo Linkievicz, et al.
Published: (2024)

Teaching physicians the GPGP method promotes deprescribing in both inpatient and outpatient settings
by: Aaron Jason Bilek, et al.
Published: (2019)

Deprescribing in an outpatient medical clinic at a tertiary care hospital in Sri Lanka
by: U. A. W. L. Perera, et al.
Published: (2024)

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center
by: Taylor M. Epperson, et al.
Published: (2023)

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center - ADDENDUM
by: Taylor M. Epperson, et al.
Published: (2023)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
by: Katherine Le Bosquet, et al.
Published: (2019)

MONTELUKAST IN TREATING ALLERGIC DISEASES
by: T.V. Kulichenko
Published: (2006)

MONTELUKAST IN TREATING ALLERGIC DISEASES
by: T.V. Kulichenko
Published: (2006)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
by: Shakti Shrestha, et al.
Published: (2021)

Prevalence of dermatoses in patients referred for evaluation in an outpatient clinic of specialties
by: João Avancini, et al.
Published: (2018)

Why Deprescribing Instead of Not Prescribing?
by: Welma Wildes Amorim, et al.
Published: (2024)

Single Specialty Hospitals and Service Competition
by: Kathleen Carey, et al.
Published: (2009)

The use of montelukast for pruritus in neurofibromatosis 1
by: Nicole L. Edmonds, BA, et al.
Published: (2022)

MONTELUKAST IN THE TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN
by: I.V. Vasilevsky, et al.
Published: (2007)

MONTELUKAST IN THE TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN
by: I.V. Vasilevsky, et al.
Published: (2007)

Person-Centred Care Including Deprescribing for Older People
by: Heather Smith, et al.
Published: (2019)

"I think deprescribing is very needed in our society:" Healthcare Professional Students Perceptions of Deprescribing Education
by: Alina Cernasev, et al.
Published: (2024)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
by: Lykke I. Kaas Oldenburg, et al.
Published: (2022)

Multidisciplinary Approach to Deprescribing Sedative-Hypnotic Medications in Geriatric Primary Care
by: Danielle R. Fixen, et al.
Published: (2022)

Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists
by: Kaylee M. Lukacena, et al.
Published: (2022)

Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access
by: Sabrina Livezey, PharmD, CSP, et al.
Published: (2021)

Deprescribing-A Few Steps Further
by: Cheryl A. Sadowski
Published: (2018)

Deprescribing: Fashion Accessory or Fig Leaf?
by: Arnold G. Zermansky
Published: (2019)

Montelukast Use Decreases Cardiovascular Events in Asthmatics
by: Malvina Hoxha, et al.
Published: (2021)

Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
by: Tesfaye BA, et al.
Published: (2021)

Montelukast and Acute Coronary Syndrome: The Endowed Drug
by: Basil Mohammed Alomair, et al.
Published: (2022)

Adverse Drug Reactions (ADRs) of Montelukast in Children
by: Abdullah Al-Shamrani, et al.
Published: (2022)

Factors influencing healthcare providers' behaviours in deprescribing: a cross-sectional study
by: Chee Tao Chang, et al.
Published: (2024)

Mask use in Chinese children admitted to the outpatient department: a single-center cross-sectional study
by: Qian Yang, et al.
Published: (2024)

Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study
by: Collin M. Clark, et al.
Published: (2020)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
by: Roy L. Soiza, et al.
Published: (2021)

Deprescribing NSAIDs: The Potential Role of Community Pharmacists
by: Delsher Amedi, et al.
Published: (2024)

The Benefit of Montelukast in Atopic Dermatitis Induced by Food Allergies
by: Isaac Melamed, et al.
Published: (2017)

The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
by: Sang Bum Kim, et al.
Published: (2015)

Should we prescribe montelukast to allergic pediatric patients?
by: Yong Mean Park
Published: (2020)

Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability
by: Sung Hyun Im, et al.
Published: (2019)

Hepatitis C Treatment Among Primary Care and Specialty Providers: A Single Center Study, 2015 to 2022
by: Anna Scialli, et al.
Published: (2024)

Predictors of failed attendances in a multi-specialty outpatient centre using electronic databases
by: Chen Mark I, et al.
Published: (2005)

Rethinking Support for Pediatric Cancer Survivors Provided by Pediatric Specialty Hospital Outpatient Nurses
by: Kyoko Shimoyama and Masaru Nakamura
Published: (2023)

Rethinking Support for Pediatric Cancer Survivors Provided by Pediatric Specialty Hospital Outpatient Nurses
by: Kyoko Shimoyama and Masaru Nakamura
Published: (2023)